Health Care & Life Sciences » Healthcare Provision | Burzynski Research Institute Inc.

Burzynski Research Institute Inc. | Balance Sheet

Fiscal year is March-February. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
0.20
2.30
3.30
0.70
0.50
0.70
Other Current Assets
-
-
-
10.00
28.40
21.50
Total Current Assets
0.20
2.30
3.30
10.70
28.90
22.20
Net Property, Plant & Equipment
2.10
1.40
0.70
-
-
-
Total Assets
2.30
3.60
4.00
10.70
28.90
22.20
Accounts Payable
114.30
99.90
-
-
-
Other Current Liabilities
38.60
42.10
105.00
43.70
136.60
Total Current Liabilities
152.90
142.00
105.00
43.70
136.60
Total Liabilities
152.90
142.00
105.00
43.70
136.60
Common Equity (Total)
150.60
138.30
101.00
33.00
107.70
Total Shareholders' Equity
150.60
138.30
101.00
33.00
107.70
Total Equity
150.60
138.30
101.00
33.00
107.70
Liabilities & Shareholders' Equity
2.30
3.60
4.00
10.70
28.90

About Burzynski Research Institute

View Profile
Address
9432 Katy Freeway
Houston Texas 77055
United States
Employees -
Website http://www.burzynskiresearch.com
Updated 07/08/2019
Burzynski Research Institute, Inc. engages in the research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer. The company was founded by Stanislaw R. Burzynski in 1984 and is headquartered in Houston, TX.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.